483
Sandoz Private LimitedFDA 483 - Sandoz Private Limited - July 02, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Sandoz Private Limited in Navi Mumbai, India, from June 24 to July 2, 2024, identified a significant deficiency in the firm's procedures for preventing objectionable microorganisms in non-sterile drug products. The environmental monitoring program, particularly the microbiological laboratory's practices for capturing contaminants, was found to be inadequate, compromising the accuracy and reliability of results.
Open in Dashboard
ID · 13edb16e-88f9-4372-b066-5db63f36840b